X
Digital health M&A bounces back in Q2
https://pharmaphorum.com/news/digital-health-ma-bounces-back-in-q2/
Funding
How challenges like Brexit & insufficient patients hinder Rare Diseases research
Challenges facing Orphan Drugs & Rare Diseases Research
Microsoft and Google among funders for cloud-based R&D startup
DNAnexus focuses on cloud-based R&D
NHS op waiting figures spark calls for more investment
Health service in desperate need of investment, says think tank.
Theresa May backtracks on ‘Dementia tax’
Parties take out rival ads as social care funding row escalates.
Pharma welcomes dialogue with politicians ahead of election
Conservative and Labour politicians assure industry with warm words at conference.